Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	39.31	-111.73	-184.09
Graham Fair Price	8.78	5.87	5.39
PEG	-80.39	-1.43	7.30
Price/Book	-19.25	9.68	11.99
Price/Cash Flow	-75.48	369.11	-1505.29
Prices/Earnings	37.11	-29.62	-47.10
Price/Sales	-23.36	31.18	40.68
Price/FCF	-75.48	369.11	-1505.29
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.09	0.67	0.67
Operating Margin	-25.31	-0.30	-0.24
ROA	-25.24	-0.04	-0.03
ROE	-0.06	-0.08	-28.39
ROIC	-0.06	-0.08	-32.39
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	< 0.005	-627.87
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.12	-0.30	147.09
EPS QOQ	0.06	-0.21	220.69
FCF QOQ	0.40	4.23	954.82
Revenue QOQ	0.06	0.03	-39.13
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	66.86	57.66	-13.76
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.17	0.17	-1.33
Quick Ratio	1.99	1.88	-5.77
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4.51	4.33	-4.00
Cash	4.86	4.83	-0.65
Capex	-0.07	-0.08	-5.68
Free Cash Flow	-0.04	0.11	216.14
Revenue	1.33	1.34	1.15
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.08	1.96	-5.65
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.65	-0.25	62.26
Naive Interpretation	Member

06 - Financial Health · Weak

Rating